Start here!

Full Name *


Hospital *


City


Country


Email *


Phone Number




* Required fields

Welcome! Please complete the information to the right to launch the HAE attack questionnaire. We thank you in advance for your cooperation.

Study information

This is a Non-interventional treatment Registry of HAE patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (Ruconest). The objectives are to observe adverse events, including lack of efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest in patients diagnosed with HAE.

Partnership